Inovio Pharmaceuticals, Inc. · NASDAQ:INO
The Vanguard Group's stake in Inovio Pharmaceuticals, Inc. fell to 4.96% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group's stake in Inovio Pharmaceuticals, Inc. fell to 4.96%, 3,315,579 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 4.96%
- Shares
- 3,315,579
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.96% | 3,315,579 |
Source
Related
- Inovio Pharmaceuticals, Inc.
- The Vanguard Group
- Inovio Pharmaceuticals, Inc. shareholders
- Schedule 13G · The Vanguard Group · Apr 30, 2025
- Schedule 13G/A · The Vanguard Group · Jan 30, 2025
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Ra Capital Management, L.P. · Aug 7, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Humeau Laurent · May 21, 2026